Table 4.
no. | compound | source [species (part)] | IC50 | ref. |
---|---|---|---|---|
74 | (–)-goyazensolide | Piptocoma rufescens (leaves) | 0.56a 0.86b 1.1c |
93 97 |
75 | (–)-15-deoxygoyazensolide | P. rufescens | 0.26a 1.1b 1.0c |
93 97 |
76 | (–)-2′,3′-dihydro-15-deoxygoyazensolide | P. rufescens | 0.58a | 93 |
77 | (+)-rufescenolide A | P. rufescens | 1.9a | 93 |
78 | (–)-5-epiisogoyazensolide | P. rufescens | 0.28a | 93 |
79 | (–)-lychnopholide | P. rufescens | 1.4a | 93 |
80 | (+)-rufescenolide B | P. rufescens | 6.6a | 93 |
81 | (+)-4,5-dihydrolychnopholide | P. rufescens | 0.56a | 93 |
82 | (+)-rufescenolide C | P. rufescens | 0.15a | 94 |
83 | (+)-eremantholide C | P. rufescens | >10a | 93 |
84 | (–)-ereglomerulide | P. rufescens | 1.2a 4.3b 4.3c |
93 97 |
85 | (+)-rufesolide A | P. rufescens | 3.0a 10.0b 8.0c |
93 97 |
86 | (–)-rufesolide B | P. rufescens | 4.0a | 93 |
87 | (+)-rufesolide C | P. rufescens | 1.4a | 93 |
88 | (+)-rufesolide D | P. rufescens | 1.0a | 93 |
89 | parthenolide | Michelia champaca (trunk bark) | 10.0b 7.5c >10d 7.5e 2.4f >10g 1.4h |
91 97 105 106 108 |
90 | parthalan | derived from 89 | 0.26d 1.8e |
105 |
91 | parthabine | derived from 89 | 0.24d 5.2e |
105 |
92 | 14-nitrophenoxytriazolparthenolide | derived from 89 | 0.43f 1.4g |
106 |
93 | dimethylaminoparthenolide (DMAPT) | derived from 89 | 1.7h | 108 |
HT-29 human colon cancer cell line (μM).
MOLM-13 human leukemia cell line (μM).
EOL-1 human leukemia cell line (μM).
HepG2 human hepatoma cell line (μM).
MCF-7 human breast cancer cell line (μg/mL).
HCT-116 human colon cancer cell line (μM).
A549 human lung non-small cell lung cancer cell line (μM).
Acute myelogenous leukemia (AML) cell line (μM).